ACTA1 and Alzheimer disease: L-AA also caused a slight but statistically significant upregulation of α-SMA expression compared to non-activated control cells, allowing quantifiable assessment of EV effects and enabling a more robust evaluation of the biological activity of AD-MSC-EVs.